Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Calixto-Hope G Lucas
Affiliation
University of California San Francisco
ORCID
Career Start Year
2014
Papers
48
H Index
14
Expertise
CM4AI Collaborator
Nevan J Krogan (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36227281
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
Neuro Oncol
2023
36227281
Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical features.
Neuro Oncol
2023
37711972
Radiotherapy and radiosurgery for meningiomas.
Neurooncol Adv
2023
37686092
Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series.
Int J Mol Sci
2023
36840626
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Neuro Oncol
2023
36897259
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.
Blood Adv
2023
37436963
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Neuro Oncol
2023
36993741
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Res Sq
2023
36993679
Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features.
Res Sq
2023
37503127
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
bioRxiv
2023
37292686
Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.
Res Sq
2023
36723772
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
Acta Neuropathol
2023
37711972
Radiotherapy and radiosurgery for meningiomas.
Neurooncol Adv
2023
37503127
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
bioRxiv
2023
37686092
Management and Molecular Characterization of Intraventricular Glioblastoma: A Single-Institution Case Series.
Int J Mol Sci
2023
37292686
Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution.
Res Sq
2023
36993741
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Res Sq
2023
36993679
Merlin<sup>S13</sup> phosphorylation controls meningioma Wnt signaling and magnetic resonance imaging features.
Res Sq
2023
37436963
Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs.
Neuro Oncol
2023
36723772
Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
Acta Neuropathol
2023
36840626
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
Neuro Oncol
2023
36897259
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS.
Blood Adv
2023
34825267
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.
Acta Neuropathol
2022
35395677
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
Neuro Oncol
2022
35587280
Recurrent ACVR1 mutations in posterior fossa ependymoma.
Acta Neuropathol
2022
35703914
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.
J Neuropathol Exp Neurol
2022
35759011
Intratumor and informatic heterogeneity influence meningioma molecular classification.
Acta Neuropathol
2022
35945463
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
Acta Neuropathol
2022
35667693
Giant cell myositis associated with metastatic thymoma and granulomatous hypercalcaemia.
BMJ Case Rep
2022
36382111
A case (report) for mechanistic validation of meningioma molecular therapies.
Neurooncol Adv
2022
36315366
Radiotherapy for meningiomas.
J Neurooncol
2022
35534562
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Nat Genet
2022
35061986
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
J Neurosurg
2022
34910220
Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
Acta Neuropathol
2022
35157770
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Blood Adv
2022
34825267
EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma.
Acta Neuropathol
2022
35587280
Recurrent ACVR1 mutations in posterior fossa ependymoma.
Acta Neuropathol
2022
35703914
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-Ganglioglioma.
J Neuropathol Exp Neurol
2022
35667693
Giant cell myositis associated with metastatic thymoma and granulomatous hypercalcaemia.
BMJ Case Rep
2022
35534562
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Nat Genet
2022
35759011
Intratumor and informatic heterogeneity influence meningioma molecular classification.
Acta Neuropathol
2022
35395677
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomes.
Neuro Oncol
2022
36315366
Radiotherapy for meningiomas.
J Neurooncol
2022
36382111
A case (report) for mechanistic validation of meningioma molecular therapies.
Neurooncol Adv
2022
35945463
Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
Acta Neuropathol
2022
35157770
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome.
Blood Adv
2022
34910220
Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma.
Acta Neuropathol
2022
35061986
Resection with intraoperative cesium-131 brachytherapy as salvage therapy for recurrent brain tumors.
J Neurosurg
2022
33147331
Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Arch Pathol Lab Med
2021
34128073
Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
J Neuropathol Exp Neurol
2021
1 - 50 of 96
Column Actions
Search
Recommended Authors
Jeff Liu
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
2016
Number of shared co-authors
3
M??lanie Pag??s
Institute Curie
Career Start Year
2014
Number of shared co-authors
12
Jennifer A Cotter
Children's Hospital Los Angeles
Career Start Year
2014
Number of shared co-authors
9
Suganth Suppiah
University Health Network, University of Toronto
Career Start Year
2013
Number of shared co-authors
4
Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year
2012
Number of shared co-authors
0
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year
2010
Number of shared co-authors
21
Delphine Guillemot
Institut Curie Hospital
Career Start Year
2010
Number of shared co-authors
1
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2008
Number of shared co-authors
15
Adelheid Woehrer
Medical University of Vienna
Career Start Year
2008
Number of shared co-authors
10
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year
2008
Number of shared co-authors
7
Malak Abedalthagafi
Emory School of Medicine
Career Start Year
2008
Number of shared co-authors
13
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year
2007
Number of shared co-authors
4
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2006
Number of shared co-authors
24
David Capper
Charite University Medicine Berlin
Career Start Year
2005
Number of shared co-authors
17
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year
2004
Number of shared co-authors
3
Gelareh Zadeh
University of Toronto
Career Start Year
2003
Number of shared co-authors
30
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year
2000
Number of shared co-authors
15
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Career Start Year
1997
Number of shared co-authors
8
Javad Nazarian
USA University of Zurich
Career Start Year
1995
Number of shared co-authors
13
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
9
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Career Start Year
1993
Number of shared co-authors
18
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
19
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Career Start Year
1990
Number of shared co-authors
12
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year
1988
Number of shared co-authors
14
Ho-Keung Ng
Chinese University of Hong Kong
Career Start Year
1987
Number of shared co-authors
19
David W Ellison
St. Jude Children's Research Hospital
Career Start Year
1986
Number of shared co-authors
19
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year
1986
Number of shared co-authors
8
Cynthia Hawkins
The Hospital for Sick Children
Career Start Year
1980
Number of shared co-authors
18
Gregory N Fuller
MD Anderson Cancer Center
Career Start Year
1978
Number of shared co-authors
11
Pascale Varlet
Institut de Psychiatrie et Neurosciences de Paris (IPNP), INSERM, University of Paris
Career Start Year
1963
Number of shared co-authors
16
row(s) 1 - 30 of 30
Collaborators
Arie Perry
University of California san francisco
Co-authored papers
24
David A Solomon
University of California san francisco
Co-authored papers
23
David R Raleigh
University of California san francisco
Co-authored papers
22
Stephen T Magill
Feinberg School of Medicine, Northwestern University
Co-authored papers
17
Nancy Ann Oberheim Bush
University of California san francisco
Co-authored papers
13
Michael W McDermott
University of California san francisco
Co-authored papers
12
Joanna J Phillips
University of California san francisco
Co-authored papers
11
Harish N Vasudevan
University of California San Francisco
Co-authored papers
11
Javier E Villanueva-Meyer
University of California san francisco
Co-authored papers
11
Mitchel S Berger
University of California san francisco
Co-authored papers
11
Abrar Choudhury
University of California San Francisco
Co-authored papers
10
William C Chen
University of California San Francisco
Co-authored papers
9
Kanish Mirchia
Co-authored papers
8
Steve E Braunstein
University of California san francisco
Co-authored papers
7
Manish K Aghi
University of California san francisco
Co-authored papers
6
Nicholas Butowski
University of California san francisco
Co-authored papers
6
Nalin Gupta
Co-authored papers
5
Penny K Sneed
University of California San Francisco
Co-authored papers
5
Lauren Boreta
Co-authored papers
4
Siyuan John Liu
University of California San Francisco.
Co-authored papers
4
Jacob S Young
Co-authored papers
3
Kyounghee Seo
University of California san francisco
Co-authored papers
3
Matthew S Susko
University of California San Francisco
Co-authored papers
3
Craig Horbinski
Co-authored papers
3
Samuel H Cheshier
Co-authored papers
3
Joseph F Costello
University of California san francisco
Co-authored papers
3
Sabine Mueller
University Children's Hospital Zurich
Co-authored papers
3
Zied Abdullaev
Co-authored papers
2
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers
2
Haley K Perlow
Co-authored papers
2
1 - 30